お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:無針注射器:医療機器のパイプライン評価
市場調査レポート
商品コード
357852

無針注射器:医療機器のパイプライン評価

Needle Free Injections - Medical Devices Pipeline Assessment, 2019

出版日: | 発行: GlobalData | ページ情報: 英文 161 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.72円
無針注射器:医療機器のパイプライン評価
出版日: 2019年05月08日
発行: GlobalData
ページ情報: 英文 161 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、無針注射器関連のパイプライン製品について調査しており、開発段階別の動向や製品の主要開発企業、現在継続中の治験、業界における近年の動向などの情報をお届けします。

第1章 目次

第2章 イントロダクション

  • 無針注射器の概要

第3章 開発中の製品

  • 無針注射器 - パイプライン製品:開発段階別
  • 無針注射器 - パイプライン製品:地域 (国) 別
  • 無針注射器 - パイプライン製品:規制経路別
  • 無針注射器 - パイプライン製品:承認時期別 (推定)

第4章 無針注射器 - 開発中のパイプライン製品:企業別

  • 無針注射器企業 - パイプライン製品:開発段階別
  • 無針注射器 - パイプライン製品:開発段階別

第5章 無針注射器 開発企業と製品の概要

  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Crossject SA
  • Enable Injections, LLC
  • Eternity Healthcare Inc.
  • EuroJet Medical Kft.
  • Glide Pharmaceutical Technologies Limited
  • Inovio Pharmaceuticals Inc
  • Medical International Technologies (Mit Canada) Inc.
  • PharmaJet, Inc.
  • Teva Pharmaceutical Industries Limited

第6章 無針注射器 - 近年の動向

第7章 付録

図表

List of Tables

  • Table 1: Needle Free Injections - Pipeline Products by Stage of Development
  • Table 2: Needle Free Injections - Pipeline Products by Territory
  • Table 3: Needle Free Injections - Pipeline Products by Regulatory Path
  • Table 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
  • Table 5: Needle Free Injections - Ongoing Clinical Trials
  • Table 6: Needle Free Injections Companies - Pipeline Products by Stage of Development
  • Table 7: Needle Free Injections - Pipeline Products by Stage of Development
  • Table 8: B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Needle-Free System - Product Status
  • Table 10: Needle-Free System - Product Description
  • Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: JetTouch System - Overactive Bladder - Product Status
  • Table 13: JetTouch System - Overactive Bladder - Product Description
  • Table 14: Crossject SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Zeneo ID Human Needle-Free Injection Device - Product Status
  • Table 16: Zeneo ID Human Needle-Free Injection Device - Product Description
  • Table 17: Zeneo IM 0.5ml Needle - Free Injection Device - Product Status
  • Table 18: Zeneo IM 0.5ml Needle - Free Injection Device - Product Description
  • Table 19: Zeneo SC 0.5ml Needle-Free Injection Device - Product Status
  • Table 20: Zeneo SC 0.5ml Needle-Free Injection Device - Product Description
  • Table 21: Zeneo SC 0.8ml Needle-Free Injection Device - Product Status
  • Table 22: Zeneo SC 0.8ml Needle-Free Injection Device - Product Description
  • Table 23: Zeneo SC High Viscosity Needle-Free Injection Device - Product Status
  • Table 24: Zeneo SC High Viscosity Needle-Free Injection Device - Product Description
  • Table 25: Enable Injections Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Enable Smart enFuse - Product Status
  • Table 27: Enable Smart enFuse - Product Description
  • Table 28: Enable Injections Inc - Ongoing Clinical Trials Overview
  • Table 29: Enable Smart enFuse - Comparison of Two Infusion Devices with Respect to Pharmacokinetics, Safety and Tolerability of Hizentra: Investigational Wearable Infusor and the Crono S-pid-50 Infusion Pump
  • Table 30: Enesi Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: ImplaVax Device - Product Status
  • Table 32: ImplaVax Device - Product Description
  • Table 33: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Multi Channel Needle-Free Injection Device - Product Status
  • Table 35: Multi Channel Needle-Free Injection Device - Product Description
  • Table 36: Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Intradermal Pen Injector - Product Status
  • Table 38: Intradermal Pen Injector - Product Description
  • Table 39: Intradermal Syringe - Product Status
  • Table 40: Intradermal Syringe - Product Description
  • Table 41: Mega Jet - Product Status
  • Table 42: Mega Jet - Product Description
  • Table 43: Multi-Port Orifices - Product Status
  • Table 44: Multi-Port Orifices - Product Description
  • Table 45: Needle-Free Vaccine Delivery Device - Product Status
  • Table 46: Needle-Free Vaccine Delivery Device - Product Description
  • Table 47: Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: MED-JET MBX Injector - Product Status
  • Table 49: MED-JET MBX Injector - Product Description
  • Table 50: MIT-H-III - Product Status
  • Table 51: MIT-H-III - Product Description
  • Table 52: MIT-H-IV-1 - Product Status
  • Table 53: MIT-H-IV-1 - Product Description
  • Table 54: MIT-H-IV-5 - Product Status
  • Table 55: MIT-H-IV-5 - Product Description
  • Table 56: MIT-H-VI Dental Injector - Product Status
  • Table 57: MIT-H-VI Dental Injector - Product Description
  • Table 58: PharmaJet Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Pre-filled Syringe - Product Status
  • Table 60: Pre-filled Syringe - Product Description
  • Table 61: Tropis - Product Status
  • Table 62: Tropis - Product Description

List of Figures

  • Figure 1: Needle Free Injections - Pipeline Products by Stage of Development
  • Figure 2: Needle Free Injections - Pipeline Products by Territory
  • Figure 3: Needle Free Injections - Pipeline Products by Regulatory Path
  • Figure 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
  • Figure 5: Needle Free Injections - Ongoing Clinical Trials
目次
Product Code: GDME0779EPD

GlobalData's Medical Devices sector report, "Needle Free Injections - Medical Devices Pipeline Assessment, 2019" provides an overview of Needle Free Injections currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Needle Free Injections pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Needle Free Injections under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Needle Free Injections and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Needle Free Injections under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Needle Free Injections Overview

3 Products under Development

  • 3.1 Needle Free Injections - Pipeline Products by Stage of Development
  • 3.2 Needle Free Injections - Pipeline Products by Territory
  • 3.3 Needle Free Injections - Pipeline Products by Regulatory Path
  • 3.4 Needle Free Injections - Pipeline Products by Estimated Approval Date
  • 3.5 Needle Free Injections - Ongoing Clinical Trials

4 Needle Free Injections - Pipeline Products under Development by Companies

  • 4.1 Needle Free Injections Companies - Pipeline Products by Stage of Development
  • 4.2 Needle Free Injections - Pipeline Products by Stage of Development

5 Needle Free Injections Companies and Product Overview

  • 5.1 B. Braun Melsungen AG Company Overview
  • 5.2 Boston Scientific Corp Company Overview
  • 5.3 Crossject SA Company Overview
  • 5.4 Enable Injections Inc Company Overview
  • 5.5 Enesi Pharma Ltd Company Overview
  • 5.6 Eternity Healthcare Inc. Company Overview
  • 5.7 Inovio Pharmaceuticals Inc Company Overview
  • 5.8 Medical International Technologies (Mit Canada) Inc Company Overview
  • 5.9 PharmaJet Inc Company Overview
  • 5.10 Queen's University Company Overview
  • 5.11 Takeda Pharmaceutical Co Ltd Company Overview
  • 5.12 Teva Pharmaceutical Industries Ltd Company Overview

6 Needle Free Injections- Recent Developments

  • 6.1 May 02, 2019: Antares Pharma reports first quarter 2019 operating and financial results
  • 6.2 May 02, 2019: Teva reports first quarter 2019 financial results
  • 6.3 Apr 30, 2019: Merck announces first-quarter 2019 financial results
  • 6.4 Apr 25, 2019: Baxter reports first-quarter 2019 results
  • 6.5 Apr 24, 2019: Boston Scientific announces results for first quarter 2019
  • 6.6 Apr 10, 2019: Enesi Pharma's ImplaVax platform shortlisted for Best New Vaccine Technology/Platform at the Vaccine Industry Excellence (ViE) Awards 2019
  • 6.7 Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving credit facility
  • 6.8 Mar 29, 2019: Daiichi Sankyo announces chief executive officer (CEO) change
  • 6.9 Mar 05, 2019: Valeritas announces fourth quarter and full year 2018 financial results
  • 6.10 Mar 04, 2019: Antares Pharma announces board changes

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.